British autocatalyst maker Johnson Matthey is planning to sell its medical device components business as the company looks to streamline its portfolio of assets, Bloomberg News reported on Wednesday.

Meanwhile, Johnson Matthey posted revenue of 11.67 billion pounds for the year ended March 31, down 9% on year. Its operating profit grew to 538 million pounds from 249 million pounds, ...

Investing.com -- Standard Investments has cut its stake in Johnson Matthey (LON: JMAT) by half, scaling back after a six-month activist campaign that led to sweeping changes at the British specialty ...

Analysts at Berenberg raised their target price on chemicals and sustainable technologies company Johnson Matthey from ...

Johnson Matthey employs 11,600 people across more than 30 countries, including a large manufacturing plant in Royston, Hertfordshire. The market seems to welcome Standard Investments ...

Johnson Matthey's (LON:JMAT) stock is up by a considerable 56% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...

Standard published an open letter last year accusing Johnson Matthey's board of presiding over "sustained underperformance" ...

Shares in Johnson Matthey soared over 30% on Friday after the investment arm of New York-based industrial firm Standard Industries took a 5.23% stake in the British chemicals maker.

Johnson Matthey shares tumbled after the chemical company warned of lower profits and said it intends to sell its battery-materials business as it doesn’t expect it to generate adequate returns.

Johnson Matthey (JMAT.L) and state investor Finnish Minerals Group (FMG) have agreed to build a plant to produce cathode materials used in electric vehicle (EV) batteries.

Activist investor Standard Investments has halved its stake in London-listed Johnson Matthey after a six-month campaign that forced the British specialty chemicals company into a major overhaul ...